-
Panbela Therapeutics (PBLA) Announces Exercise of Warrants and Issuance of New Warrants for $1.9M in Proceeds
-
Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds Priced At-the-Market
-
Panbela Announces Closing of Approximately $8.5 Million Public Offering
-
Panbela Therapeutics Inc. (PBLA) Prices $8.5M Share and Warrant Offering at $3.75/sh
-
Panbela Announces Pricing of Approximately $8.5 Million Public Offering
-
Panbela Announces Closing of Approximately $15 Million Public Offering, and Regains Compliance with Nasdaq Listing Standards
-
Roth Capital Resumes Panbella Therapeutics (PBLA) at Buy, PT $10
-
Panbela Therapeutics Inc. (PBLA) Prices Approximately $15 Million Public Offering of Common Stock, Warrants
-
Panbela Announces Pricing of Approximately $15 Million Public Offering
-
Panbela Announces Pricing of Approximately $15 Million Public Offering
-
Panbela Therapeutics Inc. (PBLA) Prices Approximately $6 Million Public Offering
-
Panbela Announces Pricing of Approximately $6 Million Public Offering
-
Panbela Announces Pricing of Approximately $6 Million Public Offering
-
UPDATE: Roth Capital Starts Panbella Therapeutics (PBLA) at Buy

